Comparison of the Efficacy & Safety of Resusix With FP24 in Patients With Acquired Coagulopathy

Summary

Phase 2a study to assess the safety and efficacy of IV infused spray-dried solvent/detergent -treated plasma (Resusix) when compared with an equal volume of plasma frozen within 24 hours after phlebotomy (FP24) in patients with liver disease who are actively bleeding or who require prophylaxis for surgical bleeding

Timeline

Start

2018-12-14

Primary completion

2020-04-15

Completion

2020-04-15

Outcome

Outcome not reported

Stopped (Business): “Convenience of Government Funding Sponsor”

Drugs

Indications